Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Healthineers Covid Test Profits Safe as Cellex Drops Suit (1)

Aug. 5, 2022, 8:36 PMUpdated: Aug. 8, 2022, 8:34 PM

Cellex Inc. dropped its patent-infringement suit over the design of Siemens Healthineers AG’s Clinitest rapid Covid-19 antigen self-test just six days after filing the complaint, clearing the cloud it cast over their sizable sales, a filing in Delaware federal court says.

Cellex’s notice of voluntary dismissal, filed Aug. 4 in the US District Court for the District of Delaware, contained no details and didn’t mention a settlement. Cellex remains free to refile the suit.

Healthineers’ chief financial officer, Jochen Schmitz, told CNBC Aug. 3 that the company wasn’t expecting “any material effect” from Cellex’s suit. “It’s a design ...